This study reports the immunomodulatory activity on human Monocyte Derived Dendritic Cells (MDDCs) of a vaccine preparation shown to be effective against an HPV16-related tumour in an animal model. The vaccine is composed of extract from Nicotiana benthamiana leaves containing HPV16 E7 protein expressed by a potato virus X-derived vector (NbPVX-E7). The effect of the extract was evaluated on MDDC differentiation and maturation by monitoring the phenotypic expression of specific markers. The results show that NbPVX-E7 does not induce monocyte differentiation to dendritic cells, but does induce MDDC maturation. Plant extract does not influence MDDC-uptake of E7-FITC while it significantly improves the Ovalbumin-FITC uptake, considered as a model antigen. Importantly, NbPVX-E7-pulsed MDDCs/PBMCs are able to prime human blood-derived lymphocytes from healthy individuals to induce HPV16 E7-specific cytotoxic activity. This is a propaedeutic study for a possible use of E7-containing plant extract in human immunotherapy of HPV-related lesions.
This study reports the immunomodulatory activity on human Monocyte Derived Dendritic Cells (MDDCs) of a vaccine preparation shown to be effective against an HPV16-related tumour in an animal model. The vaccine is composed of extract from Nicotiana benthamiana leaves containing HPV16 E7 protein expressed by a potato virus X-derived vector (NbPVX-E7). The effect of the extract was evaluated on MDDC differentiation and maturation by monitoring the phenotypic expression of specific markers. The results show that NbPVX-E7 does not induce monocyte differentiation to dendritic cells, but does induce MDDC maturation. Plant extract does not influence MDDC-uptake of E7-FITC while it significantly improves the Ovalbumin-FITC uptake, considered as a model antigen. Importantly, NbPVX-E7-pulsed MDDCs/PBMCs are able to prime human blood-derived lymphocytes from healthy individuals to induce HPV16 E7-specific cytotoxic activity. This is a propaedeutic study for a possible use of E7-containing plant extract in human immunotherapy of HPV-related lesions.
Human Papillomavirus (HPV) infection being associated with benign and malignant lesions of skin, oral and genital tract, is a major public health burden worldwide. HPVl6 is the most frequent genotype in cervical cancer (cq and its precursor lesions (CIN) in all geographic regions (l) . Prophylactic vaccines against HPVI6, 18, 6 and 11 infections have been available since 2006 (2) . These vaccines will be effective against new infections, thus a clear need exists to improve therapies to cure established HPV infections, and associated cancer lesions by developing therapeutic vaccines (3) . No therapeutic vaccines are currently licensed for human use, although a considerable number of potential systems have been used in preclinical models and in clinical trials (4) . Several studies have documented the ability of dendritic cells pulsed with the viral proteins E7 and E6, the tumour specific antigens, to stimulate in vitro specific cell-mediated immune response against tumour cells, including CC cells (5) (6) . We have previously reported the efficacy of a therapeutic vaccine against the HPV16-associated tumour in an animal model. The vaccine is based on HPVl6 E7 expressed in Nicotiana benthamiana (Nb) plant by a potato virus X (PVX)-derived vector. Mice immunized with crude foliar extract containing E7 (NbPVX-E7) showed a stimulation of humoral and cell-mediated immune responses and also showed protection against a syngenic tumour challenge. The results also suggested an adjuvant-like activity of the foliar extract (7) (8) . In this study we investigate the immunological activity of NbPVX-E7 on human blood-derived cells of healthy donors. We report the NbPVX-E7 effects in vitro on the MDDC differentiation and maturation, the possible involvement of the plant extract in the antigen-delivery into MDDCs, and the capacity of NbPVX-E7-pulsed MDDCs/PBMCs to prime E7specific lymphocytes.
MATERIALS AND METHODS

HP V16 £7 protein purification and labelling
Cloning and expression ofHPVl6 E7 has already been described (9) . Briefly, the His-E7 protein was purified by Ni-NTA resin from E.coli inclusion bodies using a denaturing buffer containing 8 M urea (Buffer B). To reduce the endotoxin content the E7-Ni-NTA beads were subjected to sequential washes using buffers containing 1% Triton-X 114, 10% Glycerol, 20% Ethanol and 60% Isopropanol (10) (11) . The protein was eluted from the packed E7-Ni-NTA resin for gravity-flow using 500 mM Imidazole and then dialysed against 25 mM Tris-HCl pH 7.2,100 mM NaCl (TN buffer), overnight at 4°C. The His-E7 protein was quantified by standard methods (Protein BC assay, BIORAD). Purity and identity of E7 were monitored by SDS-PAGE followed by Coomassie brilliant blue staining and Western-blotting (9) . The purified protein was then mixed with an equal volume of Polymyxin B (PMB)-agarose (Detoxi-Gel endotoxin-removing gel; Pierce Thermoscientific) in a buffer containing 0.5 M NaCI according to the manufacturer's instructions. The procedure was repeated until the level of endotoxins in the E7 preparation was inactive to induce MDDC maturation. No changes in the expression of specific phenotypic markers (CD80, 83, 86, MHC I and II) were induced using up to 50 ug/ml of the His-E7 bulk. The LPS-content in the E7 preparation was about 0.05 Units/ug of protein as detected by the Limulus Amoebocyte Lysate analysis (QCL-IOOO Chromogenic LAL tests, Lonza Group). His-E7 was FITClabelled (E7-FITC) in 20 mM HEPES buffer using the Protfrn" Fluorescein Labelling Kit (Vector laboratories). The excess of labelling reagent was removed by overnight dialysis against TN buffer in 10 000 MWCO (molecularweight cut-off) tubes. The relative quantity ofE7-FITC was monitored after electrophoresis on a Coomassie-stained SDS-Polyacrylamide gel by evaluation of the molecular mass shift of the labelled-E7 in respect to the unlabelled-E7. The E7-FITC was stored at -80°C until use.
Preparation and standardisation ofplant extracts
Plant production and extraction protocols have been described in detail elsewhere (7) (8) . Briefly, two leaves of N benthamiana plants, at the four-leaf stage, grown in a containment greenhouse (Biosafety level 2) were mechanically inoculated with 10 ug of pPVX-PGIPss-E7 plasmid expressing the HPV 16E7 protein targeted to the plant secretory pathway (8) . The pPVX-wt plasmid, without insert, was used as a control. Inoculated and systemic leaves were collected at the infection symptom appearance and stored at -80°C. Part of the foliar material was lyophilized by freezedrying (Freeze-dryer Modulyo, Boc Edwards SpA, Milan, Italy) and the leaf powder was stored at room temperature (RT) or at 4°C for at least one year, without loss of the E7 content. Frozen samples of infected leaves were ground to a fine powder with a pestle, rinsed and homogenized in phosphate-buffered saline (PBS). Homogenized tissues were centrifuged at 4°C, 12000 x g, for 10 min. The Total Soluble Protein (TSP) content in the supernatant (l mg/ml) was determined by Bradford assay (BioRad Laboratories) using bovine serum albumin (BSA) as a standard. The presence and reactivity of the E7 protein was evaluated by enzymelinked immunosorbent assay (ELISA) and its quantity in the extracts by a quantitative triple antibody sandwich ELISA using a rabbit anti-E7 polyclonal antibody in respect to known quantities of purified recombinant His-E7 diluted in plant extracts (7) . The E7 concentration in the plant extract bulk was estimated to be 5 ug/ml. To remove the LPS from the extract, small aliquots (l ml) of 10% NbPVX-E7 in RPMI medium were added to 0.5 ml of PMB-agarose (LPS binding capacity 2 ug/ml) and incubated for 15 min at room temperature. After removal of the beads, the samples were filtered, supplemented with 10% ofFCS and used on human cells. The LPS-content in the plant extract preparation was about 0.1 Units/ml of extract as detected by the Limulus Amoebocyte Lysate analysis. The equipment used in extract preparation was disposable and endotoxin free. The stainless steel equipment was sterilized in 30% HP2 and 2N NaOH; solutions and medium were purchased as endotoxin free.
Isolation of Peripheral Blood Mononuclear Cells (PBMCs), Peripheral Blood Lymphocytes (PBLs), immature and mature Monocyte-Derived Dendritic Cells (MDDCs)
PBMCs were obtained by centrifugation on Ficoll-Paque Plus (Lympholyte) density gradient from HLA-A2+ buffy-coats of male healthy donors at the Italian Transfusion Centre (Policlinico Umberto I, Rome, Italy).
Highly enriched monocyte populations (99% CDl4+) were purified by positive selection with anti-CDI4-mAb-conjugated magnetic microbeads, according to the manufacturer's instructions (Milteny Biotech). To obtain immature dendritic cells (iMDDCs), monocytes were cultured for 5 days at 8 x 10 5 cells/ml density in RPMI 1640 complete medium, supplemented with 50 ng/ml of Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF, PeproTech Ltd.), and 1000 D/ml ofInterieukin 4 (IL-4, R&D System), at 37°C in humidified 5% CO 2 atmosphere (12). GM-CSF and IL-4 were replenished on day 4 of culture. Mature MDDCs (mMDDCs) were obtained by an additional 24 h treatment with 200 ng/ml of E. coli LPS (Sigma-Aldrich) (13) . Fractions of PBLs were cryopreserved in freezing medium (90% FCS and 10% DMSO) in liquid nitrogen until use. All solutions and culture medium were purchased as endotoxin free.
Cell lines and mortality assay
The HPV 16 positive cervical cancer cell lines, CaSki (HLA-A2+) and SiHa (HLA-A2-), and the lymphoblastoma cell line K562 (HLA-A2+) were maintained in complete RPMI 1640 (Euroclone) medium supplemented with 2 mM L-glutamine (Euroclone), 100 Uzml penicillin (Euroclone), 100 ug/ml streptomycin (Euroclone) and 10% Foetal Calf Serum (FCS, Euroclone) at 37°C in a humidified 5% CO 2 atmosphere. All solutions and medium were purchased as endotoxin free.
To evaluate cell mortality induced by plant extract, cells at 1 x 10 6 cells/ml density were incubated 10 min at RT with 4 III of 50 ug/ml propidium iodide (PI) solution (14) . Cells were analysed by flow cytometry using a FACSCalibur flow cytometer (BD-Biosciences). At least 1 x 10 4 events were acquired and analysed by the CellQuest software program (BD).
Antibodies andflow cytometry analysis
The analysis ofthe phenotypic cell markers was carried out after incubation for 15 min at 4°C with Fluorescein Isothiocyanate (FITC) or Phycoerythrin (PE) labelled monoclonal antibodies (mAbs). The mAbs used were the following: CDia-FITC, CDl4-PE, CD80-FITC, CD83-FITC, CD86-FITC, HLA-ABC FITC and HLA-DR FITC (BD-Pharmingen). HLA-A2+ haplotype determination of PBMCs was performed by FITC-labelled anti-HLA-A2 monoclonal antibody (Clone BB7.2; BD Pharmingen) for 20 min at 4°C, a FITC-labelled mAb against a non-reactive haplotype was used as control. The antibody excess was eliminated by wash with PBS containing 2% FCS (PBSF) and the cells were analysed by flow cytometry.
MDDC-uptake
E7-FITC, 10 ug, or Ovalbumin-FITC, 10 ug, (Ova-FITC, Sigma-Aldrich) were mixed with 100 III of foliar extract in PBS and incubated 20 min at RT. The mixtures were used to pulse 1 x 10 6 immature (i-) and mature (m-) MDDCs cells in 1 ml, at either 4°C or 37°C for 3 h maximum time, in 24 well plates. Endocytosis was stopped by three washes with cold PBS. Fluorescent proteins externally bound to the cell membranes at 37°C were removed, incubating the samples with a 0.025% Trypsin 0.01% EDTA solution for 10 min at 37°C. Cell fluorescence was quantified by flow cytometry and expressed as difference of the Mean Fluorescence Intensity (MFI) between the samples incubated at 37°C and 4°C (LlMFI = MFl w c -MFI 4oc ) '
Microscopy analysis
After protein uptake, cells were fixed at RT with 4% Paraformaldehyde-PBS solution, pH 7.4, washed in PBS containing 100 mM Glycine (PBS-Gly) and incubated at 37°C for 20 min with 0.5 mg/ml RNasi A. After a wash in PBS-Gly, cells were spun onto microscope slides (Cytoslide" -Shandon) by cytospin at 300 x g. Samples were air dried and mounted with glass coverslips in 10 III of Vectashield mounting medium (Vector Laboratories). For confocal microscopy analysis plasma membrane of the MDDCs cells was stained with 8 11M DiI (1, I 'dioctadecyl-3,3,3' ,3' -tetramethylindocarbocyanine perchlorate) in cold PBS for 10 min at RT. To localise the cell nuclei, DNA was stained with 10 III of PI in Vectashield medium. After 16 h at 4°C, the slides were analysed by fluorescence and confocal microscopy.
MDDC and PBMC pulsing
Mature MDDCs (2.5 x 10 6 cells/ml) (15) and PBMCs (I x 10 7 cells/ml) were pulsed with NbPVX-E7 or NbPVX; 100 III of NbPVX-E7 (containing 0.5 ug E7) or NbPVX, was added to 2.5 x 10 6 cells in a final volume of I ml and incubated for 3 h with occasional shaking. As a control, mMDDCs/PBMCs were pulsed with 25 ug of E. coli-produced His-E7 oncoprotein, alone or mixed with the intracellular-delivery agent DOTAP (ROCHE) (16) (17) . The His E7-DOTAP complexes were mixed with mMDDCs or PBMCs in a total volume of 1 ml of RPMI and incubated at RT with occasional shaking for 3 h. At the end of incubation the cells were washed twice with PBS and resuspended at 1 x 10 6 cells/ml in RPMI plus 5% AB human serum. Cells were maintained at 37°C in an incubator with a humidified 5% CO 2 atmosphere.
T cell priming in vitro by stimulation with pulsed MDDCs andPBMCs
Pulsed mMDDCs and PBMCs were used to stimulate autologous lymphocytes (PBLs) of HLA-A2+. Thawed PBLs were co-cultured with autologous pulsed MDDCs at 10:I to 20: 1 PBLlMDDC cell ratio in I x 10 7 cells/ml cell density, in RPMI supplemented with 5% human serum AB and 20 UI/ml recombinant human IL-2 (Chiron) and incubated at 37°C. The cytokine was added to the cultures every 4 days. The PBLs were stimulated 4 times at weekly intervals with autologous pulsed PBMCs at I: I PBLlPBMC cell ratio. Pulsed MDDCs and PBMCs were y-irradiated at 3000 rad before being co-cultured with PBLs.
Cytolitic activity oflymphocytes
Cytolytic activity of MDDC-stimulated lymphocytes was evaluated using a non-radioactive colorimetric assay for flow cytometry (ACT I, Cell Technology Inc). Target cells CaSki (HPVI6+, HLA-A2+), SiHa (HPVI6+, HLA-A2-) and K562 (HPVI6-, HLA-A2+) were stained with I f.!M carboxyfluorescein diacetate succinimidyl ester (CFSE) in PBS. After 10 min at RT, the cells were washed and incubated overnight at 37°C in 5% CO 2 atmosphere. Next day, the CFSE-Iabelled cells (target cells, T) were co-incubated with autologous MDDC/PBMC-stimulated PBLs (effector cells, E) at the target/effector ratios (T: E) of I :20, I :50 and I: 100. After 4 h of incubation, cell lysis was evaluated by adding to the co-cultures the 7-Aminoactinomycin 0 (7AAD), a fluorescent dye that enters only into lysed cells binding to the DNA. Samples were analyzed by flow cytometer using FL-l (CFSE) and FL-3 (7AAD) filters. As a control, the auto-fluorescence of untreated cells and the fluorescence of single stained target cells (CFSP or 7AAD+) were also acquired by flow cytometry. Target cells labelled with the tracking dye CFSE were gated from the effector cells, and the percentages of live target cells (CFSE+/7AAD-) and dead target cells (CFSP/7AAD+) were measured.
Statistical analysis
Statistical analysis of the results was performed using Student's t-test and X2-test. P-values were two-sided with a value of <0.05 considered statistically significant.
RESULTS
N. benthamiana plant extract toxicity
In order to determine treatment conditions of human blood-derived cells, PBMCs, immature (i-) and mature (m-) monocyte-derived dendritic cells (MDDCs) were incubated at different time intervals in culture medium containing different quantities of N. benthamiana (Nb) foliar extract. This extract was prepared from tobacco plant infected with PYX (NbPVX) or PVX-E7 (NbPVX-E7) recombinant viral vectors (8) . Plant extract toxicity was then evaluated analysing the cell death using a PI assay (14) . Fig. 1 panel A shows the mortality rate of the 3 cell types, PBMCs, i-and mMDDCs, after 24 h of treatment with culture medium containing an extract quantity ranging from 5 to 50 percentage by volume (% v/v). The results show that the extract toxicity is dose-dependent. Culture medium containing 25% and 50% of extract appears to be highly toxic for the cells. On the contrary, cells treated with medium containing 5% and 10% of extract show a mortality rate not very different from that of the untreated cells, which was 10% for PBMCs, 8% for iMDDCs and 15% for mMDDCs. Considering this result, PBMCs, i-and mMDDCs were treated with medium containing 10% of either NbPVX-E7 or NbPVX for 1, 3 and 24 h, and the cell mortality was compared to that of untreated cells. The results are shown in Fig.  1 panel B . The treatment for 24 h with NbPVX-E7 induces a statistically significant mortality rate only in iMDDCs. On the contrary, both the NbPVX-E7 and NbPVX extracts did not induce statistically significant changes in the mortality rate ofPBMCs, iand mMDDCs after the I hand 3 h treatments, when compared to the untreated cells. Similar results were also obtained using extracts from plants uninfected by PYX (data not shown). According to these results, the experiments were then performed using 10% of plant extract in the medium cell culture. As the cell-death rate detected in blood-derived cells from different donors was variable, the cell mortality was evaluated in each of the experiments performed.
Effects of N. benthamiana plant extract on MDDC differentiation and maturation
We investigated whether NbPVX-E7 and NbPVX are able to modulate the monocyte differentiation in dendritic cells and their maturation, as reported for other plant extracts (18) (19) (20) (21) (22) . Monocytes differentiate into immature dendritic cells (iMDDC) when they are treated with GM-CSF and IL4 cytokines (12) . The monocytes were then cultured with 10% foliar extract without either the GM-CSF or IL4, or with only the GM-CSF or IL4. In all these conditions the monocytes show a progressive macrophage morphology, maintaining a CD 14+, CD 1a-phenotype and lacking the expression of specific MDDC markers. To analyse the possible maturation effect of the foliar extract iMDDCs, obtained from monocytes after GM-CSF and IL4 treatment, were pulsed for 24 h with NbPVX-E7 or NbPVX extract and with B 1~·.
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,... As the plant-extract maturation activity was not eliminated by Polymyxin-affinity chromatography, it could be hypothesized that the extracts contain heat-resistant constituents inducing MDDC' maturation other than microbial LPS.
Antigen-uptake mediated by N benthamiana plant extract
To investigate the possible contribution of plant extract to the E7-delivery into antigen presenting cells, i-and mMDDCs were pulsed for 3 h, at 37°C with FITC-Iabelled His-E7 (E7-FITC) mixed in vitro with NbPVX extract. Parallel experiments were performed with NbPVX mixed with FITClabelled Ovalbumin (Ova-FITC) as a model antigen. Fluorescent proteins in the cells were monitored by flow-cytometry and microscopy analysis. The histogram plots in Fig. 3 show the results of a representative experiment of uptake. A duplicate sample of each treatment was incubated at 4°C to block the cellular mechanisms of uptake, as a control. At this temperature, i-and mMDDCs pulsed with E7-FITC show an unexpected shift of fluorescence intensity (Panel A, shaded plots) NbPVX E7 LPS l a' 10 2 10" 1~100 10' 1(}2 10" 10" l CO 10 ' 10 2 10,) 1l)410 G 10' 10 2 10' 10" u ::
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. MDDC maturation induced by NbPVXE7 and LPS. FACS analysis of surface phenotype markers induced in iMDDCs treatedfor 24 h with medium containing 10% ofNbPVXE7 (Panel A and B), or with 200 ng/ml E.coli LPS, (Panel C and D). The specific markers indicated on the right, were detected by specific antibodies. Shadedplots represent untreated iMDDCs. Dotted lines plots represent the cells after NbPVXE7 (Panel A and B) or LPS treatment (Panel C and D). Bold lines plots represent the expression ofspecific markers after cell treatment with boiledNbPVXE7 (A), or detoxed NbPVXE7 (B) and boiled LPS (C), or detoxed LPS (D).
with respect to the auto-fluorescence plots of the untreated cells (Panel A, dotted lines). This shift of cell fluorescence intensity of the E7-FITC samples could originate from the E7-FITC adherence to the MDDC membranes, as has been previously described for some other proteins (24) (25) (26) . The presence of NbPVX induces only a weak increase of E7-FITC uptake at 4°C (Panel A, shaded plots At 37°C, the E7-FITC uptake increases in both iand mMDDCs and the presence ofNb-PVX induces only a weak increment of the E7-FITC cellular uptake (Panel A, solid line plots). In the same way, the Ova-FITC-uptake increases in i-and mMDDCs at 37°C (Panel B, white plots , dashed lines). The presence of NbPVX greatly increases the cellular uptake of Ova-FITC, especially in iMDDCs (Panel B, white plots, solid lines) .
Statistical analysis ofthe data from 10 experiments performed using cells from different blood donors is shown in Fig. 4 . Results highlight the different effects of foliar extract on the two proteins. The increase of E7-uptake observed in the presence of plant extract is not statistically significant (p> 0.05) while the increase of Ova-uptake, higher-in i-than in mMDDCs, is statistically significant, (p< 0.05) . The Ova-uptake levels at 1 hand 4 h of incubation are comparable, suggesting saturation kinetics in both i-or mMDDCs. The E7-uptakes in i-and mMDDCs are similar and seem to increase with the incubation time (data not shown). Results suggest different mechanism of MODC-uptake for the E7-and Ova-FITC. The analysis of cellular uptake by optical microscopy confirms the results obtained by FACS analysis. Fig. 5 shows images of mMDDCs pulsed 3 h with FITC-Iabelled Ova (top panels) and E7 (bottom panels) in the absence or presence of NbPVX. The images of Ova and E7 show a different staining pattern. The extract improves the Ovauptake and the image shows the accumulation of the protein into intracellular spots (Ova+NbPVX). In contrast, the cells treated with E7-FITC, with or without foliar extract (bottom panels), show a diffuse staining pattern evidencing that E7-FITC could enter the mMDDC without any extract, probably by an uptake mechanism different from Ova-FITC, as suggested by the FACS results.
To unequivocally demonstrate that FITC-Iabelled Ova and E7 enter the cells , i-and mMDDCs pulsed with the labelled proteins were analysed by confocal microscopy, after the cell membrane staining with DiI, or the nuclear DNA staining with PI. Fig. 6 panel A shows consecutive optical sections of a single mMDDC pulsed with E7-FITC+NbPVX, the plasma membrane being stained in red. The E7-staining pattern shows the protein was free in the cytoplasm, and accumulated in an intracellular site. Consecutive optical sections of a group of the mMDDCs pulsed with E7-FITC+NbPVX, are shown in panel B. The staining pattern confirms the presence of E7 in the cytoplasm, accumulated in spots and in the sections with the red-stained chromatin, therefore in the cell nucleus. The Ova-staining pattern by confocal microscopy analysis shows the protein accumulation only in cytoplasmatic sites (data not shown)..
Induction of E7-specific cytotoxic activity in PBLs using MDDCs/PBMCs-pulsed with NbPVX-E7
Mature MDDCs and PBMCs, from bloodderived cells of HLA-A2+ healthy individuals, were pulsed with NbPVX-E7, NbPVX, His-E7 and, His-E7 DOTAP, as described in the Material and Methods section. HLA-A2+ PBLs were cocultured with the autologous-pulsed mMDDCs and these were re-stimulated 4 times weekly with the autologous-pulsed PBMCs. One week after the last stimulation, the presence of specific cytotoxic lymphocytes (effector cells, E) were detected using two HPVl6-harboring target cells (T), the HLA-A2+ CaSki cells, and the SiHa cells, of a different haplotype (HLA-A2-). The K562 cells of HLA-A2+ haplotype and HPVl6 negative, were used to detect the possibly induced natural killer (NK) and lymphokine-activated killer (LAK) cells, or both. The experiments were performed using 3 different T:E ratios, I :25, I :50 and I: 100. Fig. 7 . The 4 primed-PBLs groups were not able to induce the lysis of the HPVl6-harbouring SiHa cells (HLA-A2J ( Fig. 7, SiHa) . On the contrary, the lysis of a small number of K562 cells was obtained with PBLs primed with NbPVX-E7 (13%), NbPVX (15%) and His-E7 (12%), suggesting the presence of a basal antigen-independent cell lysis. The results of 3 experiments ( Fig. 7, panel  B) show that the percentage of CaSki cell lysis increases with an increase in the number of PBLs stimulated with NbPVX-E7 and E7+DOTAP loaded MDDCs/PBMCs. Conversely, the increase in the number of PBLs stimulated with E7-or NbPVX-loaded MDDCs/PBMCs does not significantly change the percentage of CaSki cell lysis. According to the results, only the priming experiments using NbPVX-E7-and E7+DOTAP pulsed MDDCs/PBMCs were able to induce E7 specific cytotoxic activity in autologous PBLs. Notably, the E7 antigen-dose in the NbPVX-E7 pulsed MDDCs/PBMCs was only 0.2 ug 1 10 6 cells, while in E7+DOTAP pulsed MDDCs/PBMCs was 10 ug 110 6 cells.
DISCUSSION
The aim of the present study is to evaluate the capacity of a tobacco plant extract vaccine containing the HPV16 E7 protein (NbPVX-E7) to induce an immunomodulatory activity in human MDDCs from healthy donors. Four main questions were addressed: i) is the foliar extract toxic for human MDDCs; ii) is the NbPVX-E7 extract able to modulate MDDC differentiation and maturation; iii) can NbPVX extract modulate antigen-uptake by the MDDCs; iv) can NbPVX-E7 extract-pulsed MDDCs prime naive lymphocytes to induce HPVE7-specific cytotoxic activity in vitro.
The results demonstrate that the foliar extract obtained from plants infected with PYX or PVX-E7 cDNAs are not toxic for PBMCs, i-and mMDDCs when added to the medium culture at a concentration of 10% by volume. The NbPVX-E7 and NbPVX extracts did not induce differentiation of monocytes, but induced maturation of MDDCs, up-regulating the CD80, 83 and 86 specific markers in the same way that the LPS did. As the plants were grown and infected by PYX or PVX-E7 cDNAs in non-sterile conditions, the LPS presence was investigated in plant extracts. Neither the treatment of the extracts with PMB-agarose nor the extract boiling process were able to neutralize its MDDC maturation activity. This suggests that heat-resistant products mimicking the effect of LPS could be present in the foliar extracts. These products could originate from bacteria, but it cannot be excluded that they could be natural constituents of the plants.
The uptake results suggest for E7-and Ova-FITC different mechanisms of entry in MDDCs. The plant extract does not show any significant effect on the E7-delivery in both i-and mMDDCs, conversely, it significantly increases the uptake of the model antigen Ovalbumin in the same cells. E7-and Ova-FITC accumulate in the cells at a cytoplasmatic site, probably in the phagosome. In addition, the E7-FITC seems to spread in the cytoplasm (23) and then to enter the nucleus. The FACS and microscopy analysis suggest that the E7 protein, even at low temperature, adheres to the cell membrane, in a similar manner to some other proteins already described do (24) (25) (26) .
The results of T cell priming in vitro show that NbPVX-E7-pulsed MDDCs are able to prime T lymphocytes to induce a specific cytotoxic response. Interestingly, to achieve the same cytotoxic response by pulsing MDDCs with the E. coli-derived E7 protein, it is necessary to use an antigen-quantity for cell 50-fold higher (10 ug /10 6 cells) than that contained in the NbPVX-E7 extract (0.2 ug /10 6 cells). These results suggest that the plant-expressed E7 could be more immunogenic than the E. coliexpressed protein. It could be hypothesised that the foliar extract mediates a more efficient E7 crosspresentation, probably by means of the complexes formed with the foliar components (8) . It can be speculated that the high molecular mass complexes, also formed in vitro with E.coli-produced E7 and NbPVX mixture (7) , could direct the E7, which would normally diffused freely in the cytoplasm, towards the cell endocytic route. Plant components could prevent the protein degradation, allowing its long-lasting interaction with the proteins involved in the cross-presentation pathway, then driving a more efficient Th-I response (27) . The chemical nature of the compounds responsible for the immunomodulatory properties of the HPV-16 E7-containing N benthamiana extracts has to be determined for a possible and useful application in humans. In any case, our results give a clue to the immunomodulatory activity of the plant extract.
